Deutsche Bank upgraded AstraZeneca (AZN) to Hold from Sell with an unchanged price target of 10,500 GBp. The firm cites valuation for the upgrade following yesterday’s selloff.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- AstraZeneca (AZN) Shares Drop as China Probe Risks Loom
- AstraZeneca share move on China concerns ‘overdone,’ says BofA
- AstraZeneca says does not comment on ‘speculative media reports’
- AstraZeneca China an overhang, but feels ‘overdone,’ says BMO Capital
- Chinese authorities probing ‘dozens’ of AstraZeneca executives, Yicai reports